These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 3810694)
1. Parameters of altered plasma glucose levels during short intervals in diabetic patients. Inoue W; Tomino Y; Miura M; Yagame M; Watanabe S; Tamura S; Kaneshige H; Nomoto Y; Sakai H Tokai J Exp Clin Med; 1986 Mar; 11(1):67-70. PubMed ID: 3810694 [TBL] [Abstract][Full Text] [Related]
2. [Dynamic changes in the blood glucose, glycosylated hemoglobin and glycosylated serum protein values in patients with diabetes mellitus]. Kalpazanova N; Dosheva I; Klechkova L Vutr Boles; 1987; 26(6):107-10. PubMed ID: 3439144 [TBL] [Abstract][Full Text] [Related]
3. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control. Wörner W; Pfleiderer S; Rietbrock N Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651 [TBL] [Abstract][Full Text] [Related]
4. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control. Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of glycosylated serum protein in patients with diabetic nephropathy]. Li PL; Yang R; Zhou Y; Chen H; Cai DH Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1093-4. PubMed ID: 21690078 [TBL] [Abstract][Full Text] [Related]
6. Glycosylated proteins as an indicator of metabolic control in diabetes: evaluation by aminophenylboronic acid affinity chromatography. Ceriello A; dello Russo P; Curcio F; Paolisso G; Illiano G; Sgambato S; Giugliano D Acta Diabetol Lat; 1984; 21(1):49-54. PubMed ID: 6730847 [TBL] [Abstract][Full Text] [Related]
7. Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with Type 2 diabetes mellitus. Suo M; Wen D; Wang W; Zhang T Biosci Rep; 2020 May; 40(5):. PubMed ID: 32352504 [TBL] [Abstract][Full Text] [Related]
8. Glycosylated serum proteins and glycosylated hemoglobin in the assessment of glycemic control in insulin-dependent and non-insulin-dependent diabetes mellitus. Beisswenger PJ; Healy JC; Shultz EK Metabolism; 1993 Aug; 42(8):989-92. PubMed ID: 8345823 [TBL] [Abstract][Full Text] [Related]
9. An analysis of glycosylated blood proteins and blood glucose profiles over one year in patients with type 1 diabetes. Winocour PH; Bhatnagar D; Kalsi P; Hillier VF; Anderson DC Diabet Med; 1989 Nov; 6(8):709-16. PubMed ID: 2532106 [TBL] [Abstract][Full Text] [Related]
10. [Comparative study on the levels of glycosylated hemoglobin and fasting plasma glucose in diabetics]. Xiang KS Zhonghua Yi Xue Za Zhi; 1985 Aug; 65(8):449-53. PubMed ID: 3931870 [No Abstract] [Full Text] [Related]
11. Glycosylated albumin and glycosylated proteins: rapidly changing indices of glycaemia in diabetic pregnancy. Leiper JM; Talwar D; Robb DA; Lunan CB; MacCuish AC Q J Med; 1985 Jun; 55(218):225-31. PubMed ID: 4023170 [TBL] [Abstract][Full Text] [Related]
12. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Reaven PD; Herold DA; Barnett J; Edelman S Diabetes Care; 1995 Jun; 18(6):807-16. PubMed ID: 7555507 [TBL] [Abstract][Full Text] [Related]
13. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM. Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091 [TBL] [Abstract][Full Text] [Related]
14. [Correlation of glycosylated serum protein and glycosylated hemoglobin in patients with diabetes mellitus type 2 at various stages of metabolic compensation]. Plechanow J; Bartosiewicz W; Szczepanik Z Pol Arch Med Wewn; 1987 Sep; 78(3):149-53. PubMed ID: 3271294 [No Abstract] [Full Text] [Related]
15. The usefulness of micro- and macrochromatographic determinations of glycohemoglobin in diabetic patients with nephropathy. Saloranta C; Groop L; Ylinen K; Teramo K; Tolppanen EM; Tallgren LG Clin Nephrol; 1986 Apr; 25(4):186-92. PubMed ID: 3516481 [TBL] [Abstract][Full Text] [Related]
16. Fingerstick glycosylated hemoglobin, plasma protein, and albumin. Rendell M; Brannan C; Nierenberg J; Rasbold K; Hestorff T Diabetes Care; 1987; 10(5):629-32. PubMed ID: 3677984 [TBL] [Abstract][Full Text] [Related]
18. [The correlation of glycohemoglobin (HbA1) with the parameters of blood glucose control during the treatment of diabetes mellitus]. Khristov V; Nikolov M Vutr Boles; 1989; 28(6):48-52. PubMed ID: 2517370 [TBL] [Abstract][Full Text] [Related]
19. Glycosylated serum protein levels assayed with highly sensitive immunoradiometric assay accurately reflect glycemic control of diabetic patients. Gordon A; Glaser B; Wald M; Del Rio G; Della Casa L; Gross J; Cerasi E Diabetes Care; 1992 May; 15(5):645-50. PubMed ID: 1516484 [TBL] [Abstract][Full Text] [Related]
20. [Relation of diabetic markers and tumor markers--hemoglobin A1, glycosylated albumin, glycosylated protein and CEA, CA19-9 in diabetic and cancerous patients]. Maruyama S Rinsho Byori; 1985 Nov; 33(11):1306-12. PubMed ID: 3867765 [No Abstract] [Full Text] [Related] [Next] [New Search]